Ingredion IncINGR

Ingredion Inc (INGR): trades by Congress and the executive branch

Every trade in Ingredion Inc that a representative, a senator, the President or a senior official disclosed since 2017, newest report first. Each is read from the filer’s periodic transaction report and linked to it.

Latest report Sep 22, 2026 · Source · RSS feed

Trades disclosed
14since 2017
Members
5
Purchases / sales
5 / 9
Typical days to public
34median
Public after 45 days
2of 10 dated trades by Congress

Congress trade alerts · INGR · free

Get an email when anyone in Congress trades Ingredion Inc

Each new disclosure of a trade in the stock by a representative, a senator, the President or a senior official, with the filing.

An email when a member of Congress or the executive branch files a trade in INGR, with the filing. Unsubscribe in one click.

Transactions

Every INGR trade disclosed since 2017, newest report first
MemberAssetTypeAmountTrade dateLagPublicFiling
Donald TrumpPresidentINGRIngredion IncSell$1K–$15KJul 8, 202676dSep 22PDF
Donald TrumpPresidentINGRIngredion IncSell$15K–$50KMay 22, 202640dJul 1PDF
Donald TrumpPresidentINGRIngredion IncSell$1K–$15KMay 18, 202644dJul 1PDF
Lisa McClainR-MIMI09INGRIngredion Inc · SpouseSell$1K–$15KOct 14, 202538dNov 21PDF
Lisa McClainR-MIMI09INGRIngredion Inc · SpouseBuy$1K–$15KSep 25, 202527dOct 22PDF
Lisa McClainR-MIMI09INGRIngredion Inc · SpouseSell$1K–$15KJul 10, 202534dAug 13PDF
Lisa McClainR-MIMI09INGRIngredion Inc · SpouseBuy$1K–$15KJun 24, 202550dAug 13PDF
Andrea PalmDeputy Secretary, Department of Health and Human ServicesINGRIngredion IncSell$1K–$15KJun 29, 202160dAug 28PDF
Nicholas TaylorR-TXTX03INGRIngredion Inc · SpouseSell$1K–$15KMar 25, 201921dApr 15PDF
David RoeR-TNTN01INGRIngredion IncSell$15K–$50KAug 2, 201846dSep 17PDF
David RoeR-TNTN01INGRIngredion IncBuy$15K–$50KMay 10, 201833dJun 12PDF
David RoeR-TNTN01INGRIngredion IncSell$15K–$50KApr 9, 201836dMay 15PDF
David RoeR-TNTN01INGRIngredion IncBuy$1K–$15KJan 26, 201819dFeb 14PDF
David RoeR-TNTN01INGRIngredion IncBuy$15K–$50KDec 14, 201729dJan 12PDF

Members who traded INGR

MemberTradesBuysSellsLast tradedLatest report
David RoeR-TNTN01532Aug 2, 2018Sep 17, 2018
Lisa McClainR-MIMI09422Oct 14, 2025Nov 21, 2025
Donald TrumpPresident303Jul 8, 2026Sep 22, 2026
Andrea PalmDeputy Secretary, Department of Health and Human Services101Jun 29, 2021Aug 28, 2021
Nicholas TaylorR-TXTX03101Mar 25, 2019Apr 15, 2019

Source

Each trade is a line of a periodic transaction report filed under the STOCK Act, read from the report itself and linked to it. Three offices publish them, and all three are read here every hour: the House Clerk for representatives, the Senate Office of Public Records for senators, and the Office of Government Ethics for the President, the Vice President and Senate-confirmed officials (OGE Form 278-T). OGE links some officials’ reports and releases the rest on request; only linked reports are here.

The Act requires a report within 45 days of the trade; the lag counts the days from the trade to the day the report became public. Reports give each amount as a range. Amendments are marked and not counted as late; trades a later report withdrew are left out. The President’s reports and some House reports are scans of paper forms: a scanned value that does not read with certainty is shown as not read, never guessed, and the report is one click away. “Since” is the stock’s move from the trade date’s close to the latest daily close.

The same trades are in the OptimistFi MCP server’s get_congress_trades tool, by filer or by stock, for each chamber: connect it. Every House trade is free to download as CSV or JSON, and every trade here can be followed by RSS: the data.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.